Pulse Biosciences (Nasdaq:PLSE) today announced the publication of first-in-human feasibility study results for its pulsed field ablation (PFA) technology. Dr. Stefano Spiezia conducted the study at the Ospedale del Mare Center in Naples, Italy. It evaluated the effectiveness of the company's nanosecond pulsed field ablation (nsPFA) in benign … [Read more...] about Pulse Biosciences reports first-in-human data for PFA to treat benign thyroid nodules
Pulsed Field Ablation
Pulsecare gets regulatory nod for nanosecond PFA in China
Pulsecare Medical announced today that Chinese regulatory authorities granted marketing approval for its pulsed field ablation technology. Shenzhen, China-based Pulsecare develops the NxPFA nanosecond PFA system. It utilizes high-voltage nanosecond pulses for pulmonary vein isolation (PVI) in AFib treatment. The company says its technology marks … [Read more...] about Pulsecare gets regulatory nod for nanosecond PFA in China
Biotronik, CardioFocus announce pulsed field ablation distribution deal
Biotronik announced that it entered into a strategic distribution agreement with CardioFocus for pulsed field ablation (PFA) technology. The companies agreed to make Biotronik the exclusive distributor of the Centauri PFA system in select European countries. Centauri, CardioFocus' open-platform PFA system, supports focal contact force catheter … [Read more...] about Biotronik, CardioFocus announce pulsed field ablation distribution deal
Johnson & Johnson MedTech gets updated FDA nod for Varipulse PFA
Johnson & Johnson MedTech today announced FDA approval for an update to its Varipulse platform's irrigation flow rate. The company said the update to its pulsed field ablation (PFA) platform reflects its commitment to the evolution of PFA innovation. Its update came on the back of real-world clinical practice. Johnson & Johnson MedTech's … [Read more...] about Johnson & Johnson MedTech gets updated FDA nod for Varipulse PFA
NICE recommends Boston Scientific Farapulse pulsed field ablation tech
Boston Scientific (NYSE:BSX) announced today that NICE issued guidance supporting the use of pulsed field ablation (PFA) for treating AFib. The National Institute for Health and Care Excellence (NICE), which provides evidence-based recommendations to improve health and social care in the National Health Service (NHS) in England and Wales, reviewed … [Read more...] about NICE recommends Boston Scientific Farapulse pulsed field ablation tech
Johnson & Johnson MedTech adds new CMO for its Electrophysiology business
Johnson & Johnson MedTech (NYSE: JNJ) announced that it has a new chief medical & scientific officer for its Electrophysiology unit. Michael Bodner, group chair for Electrophysiology & Neurovascular, posted on LinkedIn that the company appointed Dr. Gregory Michaud to the role. Michaud, a globally recognized electrophysiologist, … [Read more...] about Johnson & Johnson MedTech adds new CMO for its Electrophysiology business
Boston Scientific wins expanded FDA nod for Farapulse PFA
Boston Scientific (NYSE: BSX) announced today that the FDA approved an expansion to the label of its Farapulse pulsed field ablation (PFA) system. Farapulse, one of the leading PFA systems for treating AFib, received a much-anticipated FDA approval last year. The system treats AFib by delivering pulsed field energy through a catheter to ablate … [Read more...] about Boston Scientific wins expanded FDA nod for Farapulse PFA
Kardium raises $250M to support pulsed field ablation system
Kardium announced today that it raised $250 million in a new financing round to support the launch of its pulsed field ablation system. New investors, including Janus Henderson Investors, Qatar Investment Authority (QIA), MMCAP, Piper Heartland Healthcare Capital, Eventide Asset Management and Eckuity Capital, led the oversubscribed round. … [Read more...] about Kardium raises $250M to support pulsed field ablation system
Field Medical raises $35M Series B to support pulsed field ablation tech
Field Medical announced today that it closed a Series B funding round worth proceeds totaling $35 million. BioStar Capital and Cue Growth led the round, which had participation from existing strategic investors, too. This funding adds to a $40 million Series A brought in earlier this year and brings the Cardiff-by-the-Sea, California-based … [Read more...] about Field Medical raises $35M Series B to support pulsed field ablation tech
Acutus to sell electrophysiology assets to EnChannel
EnChannel Medical announced today that it agreed to acquire the AcQMap platform assets from Acutus Medical. This deal centers around the AcQMap high-resolution imaging and mapping platform from Acutus. It also includes substantive intellectual property, quality and regulatory documentation and clinical data. With the agreement, EnChannel receives … [Read more...] about Acutus to sell electrophysiology assets to EnChannel
